|
1
|
Rosen SH, Castleman B and Liebow AA:
Pulmonary alveolar proteinosis. N Engl J Med. 258:1123–1142. 1958.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Trapnell BC, Whitsett JA and Nakata K:
Pulmonary alverolar proteinosis. N Engl J Med. 349:2527–2539. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mazone P, Thomassen MJ and Kavuru M: Our
new understanding of pulmonary alveolar proteinosis: what an
internist needs to know. Cleve Clin J Med. 68:977–978. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kitamura T, Tanaka N, Watanabe J, et al:
Idiopathic pulmonary alveolar proteinosis as an autoimmune disease
with neutralizing antibody against granulocyte/macrophage
colony-stimulating factor. J Exp Med. 190:875–880. 1999. View Article : Google Scholar
|
|
5
|
Tanaka N, Watanabe J, Kitamura T, et al:
Lungs of patients with idiopathic pulmonary alveolar proteinosis
express a factor which neutralizes granulocyte-macrophage colony
stimulating factor. FEBS Lett. 442:246–250. 1999. View Article : Google Scholar
|
|
6
|
Luisetti M, Kadija Z, Mariani F, et al:
Therapy options in pulmonary alveolar proteinosis. Ther Adv Respir
Dis. 4:239–248. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramirez J, Schultz RB and Dutton RE:
Pulmonary alveolar proteinosis: a new technique and rationale for
treatment. Arch Intern Med. 112:419–431. 1963. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inoue Y, Trapnell BC, Tazawa R, et al:
Characteristics of a large cohort of patients with autoimmune
pulmonary alveolar ptoteinosis in Japan. Am J Respir Crit Care Med.
177:752–762. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Inoue Y, Nakata K, Arai T, et al:
Epidemiological and clinical features of idiopathic pulmonary
alveolar ptoteinosis in Japan. Respirology. 11:S55–S60. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Seymour JF, Presneill JJ, Schoch OD, et
al: Therapeutic efficacy of granulocyte macrophage
colony-stimulating factor in patients with idiopathic acquired
alveolar proteinosis. Am J Respir Crit Care Med. 163:524–531. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu Z, Jing J, Wang H, et al: Pulmonary
alveolar proteinosis in China: a systematic review of 241 cases.
Respirology. 14:761–766. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bonella F, Bauer PC, Griese M, et al:
Pulmonary alveolar proteinosis: new insights from a single-center
cohort of 70 patients. Respir Med. 105:1908–1916. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Campo I, Mariani F, Rodi G, et al:
Assessment and management of pulmonary alveolar proteinosis in a
reference center. Orphanet J Rare Dis. 8:402013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Uchida K, Nakata K, Trapnell BC, et al:
High-affinity autoantibodies specifically eliminate
granulocyte-macrophage colony-stimulating factor activity in the
lungs of patients with idiopathic pulmonary alveolar proteinosis.
Blood. 103:1089–1098. 2004. View Article : Google Scholar
|
|
15
|
Seymour JF, Dunn AR, Vincent JM, et al:
Efficacy of granulocyte-macrophage colony-stimulating factor in
acquired alveolar proteinosis. N Engl J Med. 335:1924–1925. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Thomson CA, Allan LL, et al:
Characterization of pathogenic human monoclonal autoantibodies
against GM-CSF. Proc Natl Acad Sci USA. 110:7832–7837. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Seymour JF and Presneill JJ: Pulmonary
alveolar proteinosis: progress in the first 44 years. Am J Respir
Crit Care Med. 166:215–235. 2002.PubMed/NCBI
|
|
18
|
Huizar I and Kavuru MS: Alveolar
proteinosis syndrome: pathogenesis, diagnosis, and management. Curr
Opin Pulm Med. 15:491–498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Campo I, Kadija Z, Mariani F, et al:
Pulmonary alveolar proteinosis: diagnostic and therapeutic
challenges. Multidiscip Respir Med. 7:42012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Beccaria M, Luisetti M, Rodi G, et al:
Long-term durable benefit after whole lung lavage in pulmonary
alveolar proteinosis. Eur Respir J. 23:526–531. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Byun MK, Kim DS, Kim YW, et al: Clinical
features and outcomes of idiopathic pulmonary alveolar ptoteinosis
in Korean population. J Korean Med Sci. 25:393–398. 2010.
View Article : Google Scholar : PubMed/NCBI
|
